Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation

Keiju Aokage, Genichiro Ishii, Yoichi Ohtaki, Yoko Yamaguchi, Tomoyuki Hishida, Junji Yoshida, Mitsuyo Nishimura, Kanji Nagai, Atsushi Ochiai

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Metastatic tumor formation via vessel route begins with cancer cell extravasation from vessel lumen, migration into the connective tissue surrounding vessels, and invasion into target organ parenchyma. Epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) have been recognized to play an important role in metastatic process, however, how and where these biological changes take place in the early phase of metastatic tumor development has never been clarified. We morphologically evaluated 34 small intrapulmonary metastases formed after cancer cell extravasation from lymphatics (lymphogenic metastasis) and 40 formed in the absence of extravasation (aerogenous metastasis) in human specimens and found that isolated or small clusters of invasive cancer cells (tumor budding) were frequently observed in lymphogenic metastasis (24/34; 71%), but were never observed within aerogenous metastasis. We immunostained 34 lymphogenic metastases for 13 molecular markers of EMT and MET and scored the immunostaining intensity of cancer cells floating in lymphatic vessels (LVs), migrating into the connective tissue surrounding vessels [bronchovascular bundle (BVB)], and growing in lung parenchyma (LP). Cancer cells within BVBs stained more weakly for E-cadherin (p < 0.001), β-catenin (p < 0.001), and Geminin (p < 0.001) and more strongly for MMP-7 (p = 0.046) and Laminin-5 γ2 (p = 0.037) than tumor cells in LVs. However, cancer cells in LP exhibited resurgent E-cadherin (p = 0.011), β-catenin (p < 0.001), and Geminin (p = 0.037) expression and reduced MMP-7 (p = 0.038) and Laminin-5 γ2 (p = 0.001) expression in comparison with cancer cells in BVBs. Our results suggested that in the early phase of metastatic tumor formation cancer cells undergo dynamic phenotypic change associated with EMT and subsequent MET.

Original languageEnglish
Pages (from-to)1585-1595
Number of pages11
JournalInternational Journal of Cancer
Volume128
Issue number7
DOIs
Publication statusPublished - 2011 Apr 1
Externally publishedYes

Fingerprint

Epithelial-Mesenchymal Transition
Molecular Dynamics Simulation
Neoplasms
Neoplasm Metastasis
Geminin
Catenins
Lymphatic Vessels
Cadherins
Matrix Metalloproteinases
Connective Tissue
Lymphatic Metastasis
Biological Phenomena
Lung

Keywords

  • epithelial-mesenchymal transition
  • lung cancer
  • lymphogenic
  • mesenchymal-epithelial transition
  • metastasis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation. / Aokage, Keiju; Ishii, Genichiro; Ohtaki, Yoichi; Yamaguchi, Yoko; Hishida, Tomoyuki; Yoshida, Junji; Nishimura, Mitsuyo; Nagai, Kanji; Ochiai, Atsushi.

In: International Journal of Cancer, Vol. 128, No. 7, 01.04.2011, p. 1585-1595.

Research output: Contribution to journalArticle

Aokage, Keiju ; Ishii, Genichiro ; Ohtaki, Yoichi ; Yamaguchi, Yoko ; Hishida, Tomoyuki ; Yoshida, Junji ; Nishimura, Mitsuyo ; Nagai, Kanji ; Ochiai, Atsushi. / Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation. In: International Journal of Cancer. 2011 ; Vol. 128, No. 7. pp. 1585-1595.
@article{d23e46dcc4004b5d9542d207b2264f33,
title = "Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation",
abstract = "Metastatic tumor formation via vessel route begins with cancer cell extravasation from vessel lumen, migration into the connective tissue surrounding vessels, and invasion into target organ parenchyma. Epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) have been recognized to play an important role in metastatic process, however, how and where these biological changes take place in the early phase of metastatic tumor development has never been clarified. We morphologically evaluated 34 small intrapulmonary metastases formed after cancer cell extravasation from lymphatics (lymphogenic metastasis) and 40 formed in the absence of extravasation (aerogenous metastasis) in human specimens and found that isolated or small clusters of invasive cancer cells (tumor budding) were frequently observed in lymphogenic metastasis (24/34; 71{\%}), but were never observed within aerogenous metastasis. We immunostained 34 lymphogenic metastases for 13 molecular markers of EMT and MET and scored the immunostaining intensity of cancer cells floating in lymphatic vessels (LVs), migrating into the connective tissue surrounding vessels [bronchovascular bundle (BVB)], and growing in lung parenchyma (LP). Cancer cells within BVBs stained more weakly for E-cadherin (p < 0.001), β-catenin (p < 0.001), and Geminin (p < 0.001) and more strongly for MMP-7 (p = 0.046) and Laminin-5 γ2 (p = 0.037) than tumor cells in LVs. However, cancer cells in LP exhibited resurgent E-cadherin (p = 0.011), β-catenin (p < 0.001), and Geminin (p = 0.037) expression and reduced MMP-7 (p = 0.038) and Laminin-5 γ2 (p = 0.001) expression in comparison with cancer cells in BVBs. Our results suggested that in the early phase of metastatic tumor formation cancer cells undergo dynamic phenotypic change associated with EMT and subsequent MET.",
keywords = "epithelial-mesenchymal transition, lung cancer, lymphogenic, mesenchymal-epithelial transition, metastasis",
author = "Keiju Aokage and Genichiro Ishii and Yoichi Ohtaki and Yoko Yamaguchi and Tomoyuki Hishida and Junji Yoshida and Mitsuyo Nishimura and Kanji Nagai and Atsushi Ochiai",
year = "2011",
month = "4",
day = "1",
doi = "10.1002/ijc.25500",
language = "English",
volume = "128",
pages = "1585--1595",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation

AU - Aokage, Keiju

AU - Ishii, Genichiro

AU - Ohtaki, Yoichi

AU - Yamaguchi, Yoko

AU - Hishida, Tomoyuki

AU - Yoshida, Junji

AU - Nishimura, Mitsuyo

AU - Nagai, Kanji

AU - Ochiai, Atsushi

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Metastatic tumor formation via vessel route begins with cancer cell extravasation from vessel lumen, migration into the connective tissue surrounding vessels, and invasion into target organ parenchyma. Epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) have been recognized to play an important role in metastatic process, however, how and where these biological changes take place in the early phase of metastatic tumor development has never been clarified. We morphologically evaluated 34 small intrapulmonary metastases formed after cancer cell extravasation from lymphatics (lymphogenic metastasis) and 40 formed in the absence of extravasation (aerogenous metastasis) in human specimens and found that isolated or small clusters of invasive cancer cells (tumor budding) were frequently observed in lymphogenic metastasis (24/34; 71%), but were never observed within aerogenous metastasis. We immunostained 34 lymphogenic metastases for 13 molecular markers of EMT and MET and scored the immunostaining intensity of cancer cells floating in lymphatic vessels (LVs), migrating into the connective tissue surrounding vessels [bronchovascular bundle (BVB)], and growing in lung parenchyma (LP). Cancer cells within BVBs stained more weakly for E-cadherin (p < 0.001), β-catenin (p < 0.001), and Geminin (p < 0.001) and more strongly for MMP-7 (p = 0.046) and Laminin-5 γ2 (p = 0.037) than tumor cells in LVs. However, cancer cells in LP exhibited resurgent E-cadherin (p = 0.011), β-catenin (p < 0.001), and Geminin (p = 0.037) expression and reduced MMP-7 (p = 0.038) and Laminin-5 γ2 (p = 0.001) expression in comparison with cancer cells in BVBs. Our results suggested that in the early phase of metastatic tumor formation cancer cells undergo dynamic phenotypic change associated with EMT and subsequent MET.

AB - Metastatic tumor formation via vessel route begins with cancer cell extravasation from vessel lumen, migration into the connective tissue surrounding vessels, and invasion into target organ parenchyma. Epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) have been recognized to play an important role in metastatic process, however, how and where these biological changes take place in the early phase of metastatic tumor development has never been clarified. We morphologically evaluated 34 small intrapulmonary metastases formed after cancer cell extravasation from lymphatics (lymphogenic metastasis) and 40 formed in the absence of extravasation (aerogenous metastasis) in human specimens and found that isolated or small clusters of invasive cancer cells (tumor budding) were frequently observed in lymphogenic metastasis (24/34; 71%), but were never observed within aerogenous metastasis. We immunostained 34 lymphogenic metastases for 13 molecular markers of EMT and MET and scored the immunostaining intensity of cancer cells floating in lymphatic vessels (LVs), migrating into the connective tissue surrounding vessels [bronchovascular bundle (BVB)], and growing in lung parenchyma (LP). Cancer cells within BVBs stained more weakly for E-cadherin (p < 0.001), β-catenin (p < 0.001), and Geminin (p < 0.001) and more strongly for MMP-7 (p = 0.046) and Laminin-5 γ2 (p = 0.037) than tumor cells in LVs. However, cancer cells in LP exhibited resurgent E-cadherin (p = 0.011), β-catenin (p < 0.001), and Geminin (p = 0.037) expression and reduced MMP-7 (p = 0.038) and Laminin-5 γ2 (p = 0.001) expression in comparison with cancer cells in BVBs. Our results suggested that in the early phase of metastatic tumor formation cancer cells undergo dynamic phenotypic change associated with EMT and subsequent MET.

KW - epithelial-mesenchymal transition

KW - lung cancer

KW - lymphogenic

KW - mesenchymal-epithelial transition

KW - metastasis

UR - http://www.scopus.com/inward/record.url?scp=79551471984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551471984&partnerID=8YFLogxK

U2 - 10.1002/ijc.25500

DO - 10.1002/ijc.25500

M3 - Article

VL - 128

SP - 1585

EP - 1595

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 7

ER -